Dengue Vaccines Industry Soars with 12.9% CAGR to Reach US$1

The dengue vaccine industry is on a promising growth trajectory, with an estimated valuation of US$ 474.8 million in 2023. Anticipated demand for dengue vaccines is set to surge, with a projected sales volume CAGR of 12.9%.Dengue vaccine development has reached a pivotal phase in its lifecycle, marked by several pha...

Related Keywords

United States , Thailand , Russia , Poland , Brazil , Philippines , India , Germany , Spain , Vietnam , Republic Of , France , Malaysia , Canada , Venezuela , Italy , Indonesia , South Africa , Mexico , Delaware , United Kingdom , New York , America , , Takeda Pharmaceutical Company , Medigen Vaccine Biologics Corporation , E Ltd , Panacea Biotec , Market Insights Inc , Geneone Life Science Inc , Serum Institute Of India Pvt , Sun Pharmaceutical Industries Ltd , Merck Co , Sanofi Pasteur , Consumer Technology , Greater New York Chamber , Glaxosmithkline Plc , Access Your Visuals Packed , Dengue Vaccines Market , Latin America , Western Europe , Eastern Europe , Northern Africa , Associate Vice President , Future Market Insights , Medical Devices , Market Entry , Expansion Strategy , Feasibility Studies , Competitive Intelligence , Spinal Surgery , Market Insights , Stevie Award , Sales Enquiries ,